Tissue factor pathway inhibitor 2 (TFPI2), a member of the Kunitz-type serine proteinase inhibitor family, has been deemed as a tumor suppressor in several neoplasms, such as bladder cancer [28], cholangiocarcinoma [29], small cell lung cancer [30], and breast cancer [31]. This evidence concerns the gene TFPI2 and urinary bladder carcinoma.